Market Scenario
The Global Microarray Analysis Market is expected to witness tremendous growth during the
forecast period. Microarray analysis is a molecular biology technique that uses microchips
containing attached short DNA segments which are used for the analysis of gene expression
on a large scale. This enables medical practitioners to decide the most effective treatment
for individual patients. Microarray analysis can be used in various experiments such as
epigenetics, genotyping, biomarker profiling, translation profiling, pathway identification
mutations, and gene expression profiling. The techniques allow the scientists to analyze
several genes at a time with accurate results. The rising prevalence of genetic disorders,
increased focus on drug discovery and development, and rising demand for personalized
medicines are driving the market growth. According to the Genetic Disorders UK 2017,
every year approximately 30,000 new born children are diagnosed with genetic diseases.
Microarray analysis helps in understanding the gene patterns in different types of tumors.
They are also used for detection of cancer biomarker and also for its research. Hence the
rising prevalence of cancer and increasing investments for cancer research can drive the
market growth.
However, factors such as high costs of diagnosis, contamination, and inaccurate results are
expected to hinder the market growth during the forecast period
Get Premium Sample Copy @
https://www.marketresearchfuture.com/sample_request/896
Key players
Some of the key players for the Global Microarray Analysis Market are Affymetrix, Inc.,
Agilent Technologies, Inc., Sequenom, Inc., Roche NimbleGen, Illumnia, Inc., and Applied
Microarrays. Other companies operating in the global microarrays market are biomerieux
SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, PLC, Thermo Fisher
Scientific, and ProteoGenix.
Segmentation
The Global Microarray Analysis Market is segmented on the basis of type, application,
product type, and end-user. The Global Microarray Analysis Market, by type, is segmented
into DNA microarrays, protein microarrays, tissue microarrays, cellular microarrays,
chemical compound microarrays, glycan arrays, and phenotype microarrays. The application
segment is segmented into research, genotyping, forensic analysis, proteomics, genomics,
disease diagnosis, drug discovery, and toxicological research. The product type segment is
further sub-segmented into reagents, primers, buffers, DNA chips, reagent kits, and
instruments. The instrument category consists of scanner, hybridization oven, Multi-Channel
(MC) instrument, target preparation instrument, slide imprinters, centrifuge, and others. On
the basis of end-user, the market is categorized into pharmaceuticals, biotechnology,
hospitals and clinics, diagnostic centers, academic and research institutes, and ambulatory
care centers.
On the basis of region, the Global Microarray Analysis Market is segmented into the
Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American
region is further segmented into the US and Canada. The European region is divided into
two, namely, Western Europe and Eastern Europe. Western Europe is further classified into
Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific
region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the
rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United
Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and
Africa.
Regional Market Summary
The Microarray Analysis Market is dominated by the Americas owing to the adoption of
advanced technology for diagnosis, awareness among people for better diagnostics, and